Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Ulocuplumab CAS No.1375830-34-4
Ulocuplumab CAS No.1375830-34-4
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-4269 | 1mg | 420.00 | + Add to cart |
|
| R-R-4269 | 2mg | 710.00 | + Add to cart |
|
|
|
||||
Product description
Ulocuplumab (Anti-Human CXCR4 Recombinant Antibody/BMS-936564/MDX1338)/CAS No.1375830-34-4 is a fully human IgG4 anti-CXCR4 antibody. Ulocuplumab induces apoptosis and inhibits CXCL12 mediated CXCR4 activation-migration of chronic lymphocytic leukemia (CLL). Ulocuplumab exhibits antitumor activity in established tumors including acute myeloid leukemia (AML), non-Hodgkin lymphoma (NHL), and multiple myeloma xenograft models.
| Appearance | N/A |
|---|---|
| Molecular Weight | 146.2 (kDa) |
| Purity | >90% |
| CAS | 1375830-34-4 |
| Formula | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds of Ulocuplumab CAS No.1375830-34-4 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
